IJMS | Free Full-Text | Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors? | SpringerLink
Therapeutic Drug Monitoring of anti-TNF therapies Infliximab and Adalimumab Infliximab Drug Levels
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology
Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities - ScienceDirect
JCM | Free Full-Text | A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring - ScienceDirect
New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Assessing, managing and monitoring biologic therapies for inflammatory arthritis
Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring? | Nature Reviews Gastroenterology & Hepatology
NASPGHAN17 Therapeutic Drug Monitoring Associated with Increased Clinical Remission | gutsandgrowth
Medical management of moderate to severe luminal and perianal fistulizing Crohn's disease - American Gastroenterological Association
AGA Guideline: Therapeutic drug monitoring in IBD | GI and Hepatology News
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study - The Lancet Rheumatology
JCM | Free Full-Text | Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease—Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics
Adalimumab | Crohn's & Colitis UK
American Gastroenterological Association (AGA) on Twitter: "New clinical guideline on role of therapeutic drug monitoring in the management of #IBD now available in @AGA_Gastro https://t.co/yzwtV2FaEj https://t.co/IxiVz1xfST" / Twitter
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
Tumor Necrosis Factor (TNF) Inhibitors Therapeutic Cheat Sheet - Next Steps in Dermatology
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease
Managing complex perianal disease after anti-TNF failure: Where to go next? - ScienceDirect
